Anti-Nicotinic Acetylchone Receptor alpha 1 Antibody, clone 7C8.2

Acetylcholine receptor subunit alpha (UniProt: P02708; AChR nicotinic alpha 1) is encoded by the CHRNA1 (also known as ACHRA, CHNRA) gene (Gene ID: 1134) in human. Nicotinic Acetylcholine Receptor is a member of the ligan-gated ion channel family. It is a multi-pass membrane protein on the post-synaptic cell membrane. Nicotinic Ach receptor is a pentamer of two alpha chains and one each of the beta, delta, and gamma (in immature muscle) or epsilon (in mature muscle) chains. Two isoforms of this receptor have been described that are produced by alternative splicing. Isoform 1 is only expressed in skeletal muscle and isoform 2 is constitutively expressed in skeletal muscle, brain, heart, kidney, liver, lung and thymus. It contains an extracellular domain (aa 21-255), four helical domains (aa 256-280; 288-306; 322-341; and 454-472) and a cytoplasmic domain (aa 342-453). After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in CHRNA1 gene are linked to Myasthenic syndrome, which is characterized by muscle weakness affecting the axial and limb muscles, and the ocular muscles that lead to ptosis and opthalmoplegia. The alpha subunit is the main focus for antibody binding in myasthenia gravis.

Clone 7C8.2 detects nicotinic acetylcholine receptor alpha in human and rat. It targets an epitope within 97 amino acids from the C-terminal half.

GST/His-tagged recombinant fragment corresponding to 97 amino acids from the C-terminal half of human nicotinic acetylcholine receptor alpha.

Anti-Nicotinic Acetylchone Receptor alpha 1, clone 7C8.2, Cat. No. MABN1618, is a highly specific mouse monoclonal antibody that targets CHRNA1 and has been tested for use in Immunohistochemistry (Paraffin) and Western Blotting.

Research Category
Neuroscience

Western Blotting Analysis: 0.5 µg/mL from a representative lot detected Nicotinic Acetylchone Receptor alpha 1 in 10 µg of SW480 cell lysate.

Immunohistochemistry Analysis: A 1:50 dilution from a representative lot detected Nicotinic Acetylchone Receptor alpha 1 in human colon cancer tissue sections.

Evaluated by Western Blotting in L6 cell lysate.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected Nicotinic Acetylchone Receptor alpha 1 in 10 µg of L6 cell lysate.

~55 kD observed; 54.55 kDa calculated. Uncharacterized bands may be observed in some lysate(s).

Protein G purified

Format: Purified

Purified mouse monoclonal antibody IgG2a in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Stable for 1 year at 2-8°C from date of receipt.

Concentration: Please refer to lot specific datasheet.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.